⌘K

Home/Filings/5/0000950170-25-006883

5//SEC Filing

Brainard Diana 5

Accession 0000950170-25-006883

CIK 0000906709other

View on SEC.gov Company Profile

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 8:32 PM ET

Size

5.5 KB

Accession

0000950170-25-006883

Insider Transaction Report

Form 5

Period: 2024-12-31

NEKTAR THERAPEUTICSNKTR

Director

Transactions

Award
Stock Option
2024-09-18+120,000→ 120,000 total
Exercise: $1.26Exp: 2032-09-17→ Common Stock (120,000 underlying)

Footnotes (1)

[F1]This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.

Documents

1 file

5
ownership.xmlPrimary
5

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1

filerCIK 0001818070

Filing Metadata

Form type: 5
Filed: Jan 16, 7:00 PM ET
Accepted: Jan 17, 8:32 PM ET
Size: 5.5 KB

View on SEC.gov